Skip to main content
Clinical Trials/IRCT2015050322065N1
IRCT2015050322065N1
Completed
Phase 3

prevention of contrast induced nephropathy(CIN) in pateints with some degree of chronic kidney disease (CKD) undergoing coronary angioplasty/graphy with sodium potassium citrate solution(shohl's solution)

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences0 sites190 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
contrast induced nephropathy.
Sponsor
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Enrollment
190
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • all adult patients (more than 18 years old) candidate for elective coronary angioplasty/graphy and have CKD (at least stage 2\)
  • Exclusion criteria: ESRD (GFR less than 15cc per min); AKI; exposure to contrast within last 10 days; history of sensitivity to contrast media; pulmonary edema; multiple myeloma; history of (diarrhea, vomiting, dehydration status, bleeding);
  • pregnancy; drug history of (NAC, teofiline, dopamine, fenoldopam, manitol and
  • NaHCO3\) 48 hours before intervention; consumption of nephrotoxic drugs 48 hours before till one week following the intervention; electrolytes disturbance (i.e hyperkalemia or alkalosis) or GFR more than 90 cc per min; refusal to participate

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials